Topical simvastatin for infantile hemangioma
Part of Skin clinical trials.
This trial tests a cream containing simvastatin, a cholesterol medicine, applied to infantile hemangiomas (strawberry birthmarks) in babies aged 3-6 months. It may help shrink the birthmark without needing stronger treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is between 3 and 6 months old
- Your baby has a strawberry birthmark (hemangioma) that is at least 1 cm wide but not too large
- The birthmark is on the skin surface, not deep under the skin, and not on the lips
- The birthmark is not ulcerated (no open sore) and your baby has no other skin conditions that could interfere
- Your baby has not had any prior treatment for the birthmark (like creams, oral medicines, or laser) within the specified timeframes
- Your baby is not allergic to statins or other ingredients in the cream
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at babies with a common birthmark called infantile hemangioma (made of blood vessels) to help doctors decide the best treatment or whether monitoring is enough. It involves a first evaluation and follow-up, but no new drugs or procedures are tested.
This trial tests different starting doses of oral propranolol to see which works best and is safest for treating infantile hemangiomas that have ulcers (sores). It may help your child heal faster.
This study compares three approaches—pulsed-dye laser, timolol (a medicated skin solution), or watch-and-wait—to see which works best to slow the growth of a hemangioma birthmark in young babies. It may help find a treatment that shrinks or controls the birthmark as early as possible.
This study compares two ways of stopping propranolol in children with infantile hemangioma (a type of birthmark): stopping suddenly versus slowly reducing the dose. It aims to find out which method is safer and better at preventing the birthmark from growing back.
This study tests a cream containing simvastatin (commonly a cholesterol pill, now as a cream) to see if it can shrink fatty deposits on the eyelids. If you have these yellowish patches, using the cream might help reduce them without needing a procedure.
This pilot study tests a gel called sirolimus to see if it can safely shrink or improve raised, dark birthmarks (epidermal nevi) in people 6 and older. The gel is applied directly to the birthmark, and the study will check how well it works and if it causes any side effects.
Hear when a new Hemangioma Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.